MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 215 filers reported holding MEDICINES CO in Q1 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $8,000 | +100.0% | 173 | +33.1% | 0.00% | +100.0% |
Q2 2019 | $4,000 | -77.8% | 130 | -63.2% | 0.00% | -50.0% |
Q1 2019 | $18,000 | +100.0% | 353 | -28.1% | 0.00% | 0.0% |
Q4 2018 | $9,000 | -43.8% | 491 | -9.9% | 0.00% | -42.9% |
Q3 2018 | $16,000 | -11.1% | 545 | +5.8% | 0.01% | -12.5% |
Q2 2018 | $18,000 | -5.3% | 515 | -13.2% | 0.01% | 0.0% |
Q1 2018 | $19,000 | +18.8% | 593 | +0.7% | 0.01% | +33.3% |
Q4 2017 | $16,000 | -44.8% | 589 | -26.1% | 0.01% | -62.5% |
Q3 2017 | $29,000 | -3.3% | 797 | -1.7% | 0.02% | -5.9% |
Q2 2017 | $30,000 | 0.0% | 811 | +29.1% | 0.02% | 0.0% |
Q1 2017 | $30,000 | +87.5% | 628 | +31.7% | 0.02% | +88.9% |
Q4 2016 | $16,000 | -27.3% | 477 | -19.6% | 0.01% | -30.8% |
Q3 2016 | $22,000 | +29.4% | 593 | +16.5% | 0.01% | +30.0% |
Q2 2016 | $17,000 | +13.3% | 509 | +3.2% | 0.01% | +11.1% |
Q1 2016 | $15,000 | -57.1% | 493 | -48.5% | 0.01% | -59.1% |
Q4 2015 | $35,000 | – | 958 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |